Tag «阿伐可泮»

Avacopan

It’s only fair to share… Avacopan アバコパン авакопан [Russian] [INN] أفاكوبان [Arabic] [INN] 阿伐可泮 [Chinese] [INN] Formula C33H35F4N3O2 CAS 1346623-17-3 Mol weight 581.6435 (2R,3S)-2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]piperidine-3-carboxamide (2R,3S)-2-(4-Cyclopentylaminophenyl)-l-(2-fluoro-6-methylbenzoyl)piperidine-3- carboxylic acid (4-methyl-3-trifluoromethylphenyl)amide 3-Piperidinecarboxamide, 2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]-, (2R,3S)- (2R,3S)-2-[4-(Cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]-3-piperidinecarboxamide (2R,3S)-2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl3-(trifluoromethyl)phenyl]piperidine-3-carboxamide APPROVED PMDA JAPAN 2021/9/27, Tavneos Anti-inflammatory, Complement C5a receptor antagonist Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis Avacopan (2R,3S)-2-[4-(Cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]piperidine-3-carboxamide C33H35F4N3O2 : 581.64 [1346623-17-3] CCX 168 Avacopan wasunder investigation in clinical trial …